• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较 CSF 神经丝轻链、神经颗粒素和 tau 与 MRI 标志物。

Comparison of CSF neurofilament light chain, neurogranin, and tau to MRI markers.

机构信息

Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.

Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.

出版信息

Alzheimers Dement. 2021 May;17(5):801-812. doi: 10.1002/alz.12239. Epub 2021 Mar 4.

DOI:10.1002/alz.12239
PMID:33663022
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8119371/
Abstract

INTRODUCTION

We determined whether cerebrospinal fluid (CSF) neurofilament light (NfL), neurogranin (Ng), and total-tau (t-tau) differentially mapped to magnetic resonance imaging (MRI) measures of cortical thickness, microstructural integrity (corpus callosum and cingulum fractional anisotropy [FA]), and white matter hyperintensities (WMH).

METHODS

Analyses included 536 non-demented Mayo Clinic Study of Aging participants with CSF NfL, Ng, t-tau, amyloid beta (Aβ)42 and longitudinal MRI scans. Linear mixed models assessed longitudinal associations between CSF markers and MRI changes.

RESULTS

Higher CSF NfL was associated with decreasing microstructural integrity and WMH. Higher t-tau was associated with decreasing temporal lobe and Alzheimer's disease (AD) meta region of interest (ROI) cortical thickness. There was no association between Ng and any MRI measure. CSF Aβ42 interacted with Ng for declines in temporal lobe and AD meta ROI cortical thickness and cingulum FA.

DISCUSSION

CSF NfL predicts changes in white matter integrity, t-tau reflects non-specific changes in cortical thickness, and Ng reflects AD-specific synaptic and neuronal degeneration.

摘要

简介

我们确定了脑脊液(CSF)神经丝轻链(NfL)、神经颗粒素(Ng)和总 tau(t-tau)是否与磁共振成像(MRI)测量的皮质厚度、微观结构完整性(胼胝体和扣带回分数各向异性 [FA])和脑白质高信号(WMH)有差异。

方法

分析包括 536 名无痴呆的梅奥诊所老龄化研究参与者的 CSF NfL、Ng、t-tau、淀粉样蛋白β(Aβ)42 和纵向 MRI 扫描。线性混合模型评估了 CSF 标志物与 MRI 变化之间的纵向关联。

结果

较高的 CSF NfL 与微观结构完整性和 WMH 的减少有关。较高的 t-tau 与颞叶和阿尔茨海默病(AD)的 ROI 皮质厚度减少有关。Ng 与任何 MRI 测量都没有关联。CSF Aβ42 与 Ng 相互作用,导致颞叶和 AD 元 ROI 皮质厚度以及扣带回 FA 的下降。

讨论

CSF NfL 预测白质完整性的变化,t-tau 反映皮质厚度的非特异性变化,而 Ng 反映 AD 特异性的突触和神经元退化。

相似文献

1
Comparison of CSF neurofilament light chain, neurogranin, and tau to MRI markers.比较 CSF 神经丝轻链、神经颗粒素和 tau 与 MRI 标志物。
Alzheimers Dement. 2021 May;17(5):801-812. doi: 10.1002/alz.12239. Epub 2021 Mar 4.
2
Contribution of CSF biomarkers to early-onset Alzheimer's disease and frontotemporal dementia neuroimaging signatures.脑脊液生物标志物对早发性阿尔茨海默病和额颞叶痴呆神经影像学特征的贡献。
Hum Brain Mapp. 2020 Jun 1;41(8):2004-2013. doi: 10.1002/hbm.24925. Epub 2020 Jan 16.
3
Association between cerebrospinal fluid and plasma neurodegeneration biomarkers with brain atrophy in Alzheimer's disease.阿尔茨海默病中脑脊液和血浆神经退行性变生物标志物与脑萎缩之间的关联
Neurobiol Aging. 2017 Oct;58:14-29. doi: 10.1016/j.neurobiolaging.2017.06.002. Epub 2017 Jun 17.
4
Associations of Neurodegeneration Biomarkers in Cerebrospinal Fluid with Markers of Alzheimer's Disease and Vascular Pathology.脑脊液神经退行性变生物标志物与阿尔茨海默病和血管病理学标志物的相关性。
J Alzheimers Dis. 2023;92(3):887-898. doi: 10.3233/JAD-221015.
5
Cerebrospinal fluid biomarkers of neurofibrillary tangles and synaptic dysfunction are associated with longitudinal decline in white matter connectivity: A multi-resolution graph analysis.神经原纤维缠结和突触功能障碍的脑脊液生物标志物与白质连接的纵向下降相关:多分辨率图分析。
Neuroimage Clin. 2019;21:101586. doi: 10.1016/j.nicl.2018.10.024. Epub 2018 Oct 23.
6
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum.神经退行性变、突触完整性和星形胶质细胞激活的脑脊液生物标志物在整个临床阿尔茨海默病谱中。
Alzheimers Dement. 2019 May;15(5):644-654. doi: 10.1016/j.jalz.2019.01.004. Epub 2019 Mar 8.
7
Comparison of variables associated with cerebrospinal fluid neurofilament, total-tau, and neurogranin.比较与脑脊液神经丝、总 tau 和神经颗粒素相关的变量。
Alzheimers Dement. 2019 Nov;15(11):1437-1447. doi: 10.1016/j.jalz.2019.07.009. Epub 2019 Oct 23.
8
Association of Cerebrospinal Fluid Neurofilament Light Protein With Risk of Mild Cognitive Impairment Among Individuals Without Cognitive Impairment.脑脊髓液神经丝轻链蛋白与无认知障碍个体发生轻度认知障碍风险的相关性。
JAMA Neurol. 2019 Feb 1;76(2):187-193. doi: 10.1001/jamaneurol.2018.3459.
9
Subtle Differences in Cognition in 70-Year-Olds with Elevated Cerebrospinal Fluid Neurofilament Light and Neurogranin: A H70 Cross-Sectional Study.70 岁老年人脑脊液神经丝轻链和神经颗粒素升高认知的细微差异:一项 H70 横断面研究。
J Alzheimers Dis. 2023;91(1):291-303. doi: 10.3233/JAD-220452.
10
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease.阿尔茨海默病中的脑脊液tau蛋白、神经颗粒素和神经丝轻链蛋白
EMBO Mol Med. 2016 Oct 4;8(10):1184-1196. doi: 10.15252/emmm.201606540. Print 2016 Oct.

引用本文的文献

1
CSF total tau as a proxy of synaptic degeneration.脑脊液总tau蛋白作为突触退化的替代指标。
Nat Commun. 2025 Aug 29;16(1):8076. doi: 10.1038/s41467-025-63545-5.
2
Prediction of longitudinal synaptic loss in Alzheimer's disease using tau PET and plasma biomarkers.使用tau正电子发射断层扫描(PET)和血浆生物标志物预测阿尔茨海默病患者的纵向突触损失
Alzheimers Dement. 2025 May;21(5):e70333. doi: 10.1002/alz.70333.
3
Roles of neuroimaging markers and biomarkers in cerebral small vessel disease and their associations with cognitive function.神经影像学标志物和生物标志物在脑小血管病中的作用及其与认知功能的关联。
Front Neurol. 2025 May 1;16:1483842. doi: 10.3389/fneur.2025.1483842. eCollection 2025.
4
p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial.轻度至中度阿尔茨海默病患者的 p75 神经生长因子受体调节:一项随机、安慰剂对照的 2a 期试验。
Nat Med. 2024 Jun;30(6):1761-1770. doi: 10.1038/s41591-024-02977-w. Epub 2024 May 17.
5
Operationalizing selection criteria for clinical trials in Alzheimer's disease: Biomarker and clinical considerations.阿尔茨海默病临床试验选择标准的实施:生物标志物与临床考量
Alzheimers Dement (N Y). 2023 Nov 17;9(4):e12434. doi: 10.1002/trc2.12434. eCollection 2023 Oct-Dec.
6
Plasma NfL is associated with the APOE ε4 allele, brain imaging measurements of neurodegeneration, and lower recall memory scores in cognitively unimpaired late-middle-aged and older adults.血浆 NfL 与 APOE ε4 等位基因、脑成像测量的神经退行性变以及认知未受损的中老年人群的回忆记忆评分较低有关。
Alzheimers Res Ther. 2023 Apr 10;15(1):74. doi: 10.1186/s13195-023-01221-w.
7
Sex-specific effects of SNAP-25 genotype on verbal memory and Alzheimer's disease biomarkers in clinically normal older adults.SNAP-25 基因型对临床正常老年人群言语记忆和阿尔茨海默病生物标志物的性别特异性影响。
Alzheimers Dement. 2023 Aug;19(8):3448-3457. doi: 10.1002/alz.12989. Epub 2023 Feb 18.
8
Associations of Neurodegeneration Biomarkers in Cerebrospinal Fluid with Markers of Alzheimer's Disease and Vascular Pathology.脑脊液神经退行性变生物标志物与阿尔茨海默病和血管病理学标志物的相关性。
J Alzheimers Dis. 2023;92(3):887-898. doi: 10.3233/JAD-221015.
9
Dementia with Lewy bodies: Impact of co-pathologies and implications for clinical trial design.路易体痴呆:共病的影响及其对临床试验设计的意义。
Alzheimers Dement. 2023 Jan;19(1):318-332. doi: 10.1002/alz.12814. Epub 2022 Oct 14.
10
Sleepiness in Cognitively Unimpaired Older Adults Is Associated With CSF Biomarkers of Inflammation and Axonal Integrity.认知功能未受损的老年人的嗜睡与脑脊液中的炎症生物标志物和轴突完整性相关。
Front Aging Neurosci. 2022 Jul 11;14:930315. doi: 10.3389/fnagi.2022.930315. eCollection 2022.

本文引用的文献

1
Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum.阿尔茨海默病连续体临床前期的淀粉样β、tau、突触、神经退行性变和神经胶质生物标志物。
Alzheimers Dement. 2020 Oct;16(10):1358-1371. doi: 10.1002/alz.12131. Epub 2020 Jun 23.
2
Prevalence and Heterogeneity of Cerebrovascular Disease Imaging Lesions.脑血管病影像学病变的流行率和异质性。
Mayo Clin Proc. 2020 Jun;95(6):1195-1205. doi: 10.1016/j.mayocp.2020.01.028.
3
Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease.阿尔茨海默病患者脑脊髓液和血浆生物标志物随淀粉样蛋白沉积增加的轨迹变化。
EMBO Mol Med. 2019 Dec;11(12):e11170. doi: 10.15252/emmm.201911170. Epub 2019 Nov 11.
4
Comparison of variables associated with cerebrospinal fluid neurofilament, total-tau, and neurogranin.比较与脑脊液神经丝、总 tau 和神经颗粒素相关的变量。
Alzheimers Dement. 2019 Nov;15(11):1437-1447. doi: 10.1016/j.jalz.2019.07.009. Epub 2019 Oct 23.
5
Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without Dementia.无痴呆症个体中淀粉样蛋白、tau 蛋白和神经退行性生物标志物特征与记忆下降速度的相关性。
JAMA. 2019 Jun 18;321(23):2316-2325. doi: 10.1001/jama.2019.7437.
6
White matter hyperintensities: relationship to amyloid and tau burden.脑白质高信号:与淀粉样蛋白和 tau 负担的关系。
Brain. 2019 Aug 1;142(8):2483-2491. doi: 10.1093/brain/awz162.
7
Differential effects of neurodegeneration biomarkers on subclinical cognitive decline.神经退行性变生物标志物对亚临床认知衰退的不同影响。
Alzheimers Dement (N Y). 2019 Apr 12;5:129-138. doi: 10.1016/j.trci.2019.02.004. eCollection 2019.
8
Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer's Disease.使用脑脊液 Aβ(Aβ)42/40 比值诊断阿尔茨海默病的优缺点。
Alzheimers Res Ther. 2019 Apr 22;11(1):34. doi: 10.1186/s13195-019-0485-0.
9
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum.神经退行性变、突触完整性和星形胶质细胞激活的脑脊液生物标志物在整个临床阿尔茨海默病谱中。
Alzheimers Dement. 2019 May;15(5):644-654. doi: 10.1016/j.jalz.2019.01.004. Epub 2019 Mar 8.
10
Cerebrospinal fluid biomarkers of neurofibrillary tangles and synaptic dysfunction are associated with longitudinal decline in white matter connectivity: A multi-resolution graph analysis.神经原纤维缠结和突触功能障碍的脑脊液生物标志物与白质连接的纵向下降相关:多分辨率图分析。
Neuroimage Clin. 2019;21:101586. doi: 10.1016/j.nicl.2018.10.024. Epub 2018 Oct 23.